Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
1
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
Placebo oral tablet Phase 3 Results Expected
Placebo oral tablet • Relapsed/Refractory Follicular Lymphoma
Target Indication
Relapsed/Refractory Follicular Lymphoma
Clinical Trial
NCT04224493Last updated: 12/4/2025